Gene · 9757
Papers2,805
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,805
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current Progress on Predictive Biomarkers for Response to Immune Checkpoint Inhibitors in Gastric Cancer: How to Maximize the Immunotherapeutic Benefit? | Cancers (Basel) | 2023 | 37190201 | PubTator, text mining | PubMed |
| Peroxisome Proliferator-Activated Receptor-γ as a Target and Regulator of Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease. | Cells | 2023 | 37190114 | PubTator, text mining | PubMed |
| The Roles of Antisense Long Noncoding RNAs in Tumorigenesis and Development through Cis-Regulation of Neighbouring Genes. | Biomolecules | 2023 | 37189431 | PubTator, text mining | PubMed |
| Precise diagnosis and targeted therapy of nodal T-follicular helper cell lymphoma (T-FHCL). | Front Oncol | 2023 | 37188182 | PubTator, text mining | PubMed |
| RNA-seq analysis identifies transcriptomic profiles associated with anal cancer recurrence among people living with HIV. | Ann Med | 2023 | 37177979 | PubTator, text mining | PubMed |
| The State of Research and Weight of Evidence on the Epigenetic Effects of Bisphenol A. | Int J Mol Sci | 2023 | 37175656 | PubTator, text mining | PubMed |
| The Role of the Microbiota in Esophageal Cancer. | Cancers (Basel) | 2023 | 37174041 | PubTator, text mining | PubMed |
| GPi DBS treatment outcome in children with monogenic dystonia: a case series and review of the literature. | Front Neurol | 2023 | 37168666 | PubTator, text mining | PubMed |
| Epigenotype-genotype-phenotype correlations in SETD1A and SETD2 chromatin disorders. | Hum Mol Genet | 2023 | 37166351 | PubTator, text mining | PubMed |
| A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids. | Dev Cell | 2023 | 37148882 | PubTator, text mining | PubMed |
| Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma. | Nat Commun | 2023 | 37147298 | PubTator, text mining | PubMed |
| H3K4me3-related lncRNAs signature and comprehensive analysis of H3K4me3 regulating tumor immunity in lung adenocarcinoma. | Respir Res | 2023 | 37131252 | PubTator, text mining | PubMed |
| Forthcoming Developments in Models to Study the Hepatitis B Virus Replication Cycle, Pathogenesis, and Pharmacological Advancements. | ACS Omega | 2023 | 37125123 | PubTator, text mining | PubMed |
| HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis. | Int J Mol Sci | 2023 | 37108816 | PubTator, text mining | PubMed |
| An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review. | Genes (Basel) | 2023 | 37107631 | PubTator, text mining | PubMed |
| Epigenetic moonlighting: Catalytic-independent functions of histone modifiers in regulating transcription. | Sci Adv | 2023 | 37083523 | PubTator, text mining | PubMed |
| Dominant neoantigen verification in hepatocellular carcinoma by a single-plasmid system coexpressing patient HLA and antigen. | J Immunother Cancer | 2023 | 37076248 | PubTator, text mining | PubMed |
| Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies. | NPJ Precis Oncol | 2023 | 37072571 | PubTator, text mining | PubMed |
| Exposure to microbial products followed by loss of Tet2 promotes myelodysplastic syndrome via remodeling HSCs. | J Exp Med | 2023 | 37071125 | PubTator, text mining | PubMed |
| Three-dimensional and single-cell sequencing of liver cancer reveals comprehensive host-virus interactions in HBV infection. | Front Immunol | 2023 | 37063858 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9757/papers?page=16